Viewing Study NCT07233720


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-17 @ 3:55 PM
Study NCT ID: NCT07233720
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2025-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Sponsor: Henan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module